Vu L. Truong, Ph.D.
About Vu L. Truong, Ph.D.
Vu L. Truong, Ph.D. - Founder, CEO and Director
Vu L. Truong, Ph.D. is the Founder, CEO, and Director of Aridis Pharmaceuticals. With a career spanning over two decades, he has dedicated his professional life to the advancement of biopharmaceutical drug development. His leadership shapes the company's strategic direction and innovative initiatives.
Educational Background - Ph.D. in Pharmacology and Molecular Sciences
Vu L. Truong holds a Ph.D. in Pharmacology and Molecular Sciences from Johns Hopkins University School of Medicine. This profound academic foundation has equipped him with the expertise necessary for excelling in biopharmaceutical research and development, with a specific focus on infectious diseases.
Experience in Biopharmaceutical Drug Development
With over 20 years of experience in the biopharmaceutical sector, Dr. Vu L. Truong has significantly contributed to the field. His previous positions include roles at Gene Medicine, Aviron, and MedImmune, companies that were later acquired by larger entities, showcasing his impactful presence in the field.
Research and Development - Monoclonal Antibodies and Vaccines
Dr. Truong's work focuses on researching and developing innovative human monoclonal antibodies and vaccines aimed at combating life-threatening infections. His product development track record includes the development of notable therapeutics such as FluMist and Synagis mAb, further establishing his expertise in the sector.
Principal Architect of Aridis' Technologies
As the principal architect of Aridis Pharmaceuticals' technologies, Dr. Truong has been instrumental in the design and refinement of numerous anti-infective products and pharmaceutical processing technologies. His innovations continue to pave the way for advancements in the treatment of severe infections.